These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14199706)

  • 21. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
    HELLE I; AAS K; GODAL HC
    Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607
    [No Abstract]   [Full Text] [Related]  

  • 23. THROMBOLYSIS STUDIED IN AN ARTIFICIAL CIRCULATION: THROMBI PREPARED IN VITRO IN A CHANDLER'S TUBE.
    MCNICOL GP; BAIN WH; WALKER F; RIFKIND BM; DOUGLAS AS
    Lancet; 1965 Apr; 1(7390):838-42. PubMed ID: 14263541
    [No Abstract]   [Full Text] [Related]  

  • 24. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 25. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 26. THE INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON THE LAST STAGE OF COAGULATION.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():327-30. PubMed ID: 14073280
    [No Abstract]   [Full Text] [Related]  

  • 27. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

  • 28. HEPARIN FRACTIONATION IN THE STUDY OF LYTIC ACTIVITY.
    GREEN J
    J Clin Pathol; 1964 May; 17(3):316-8. PubMed ID: 14159470
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen.
    HOPKINS TF; MEITES J
    Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684
    [No Abstract]   [Full Text] [Related]  

  • 30. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 31. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763
    [No Abstract]   [Full Text] [Related]  

  • 32. IN VIVO ACTIVATION OF THE FIBRINOLYTIC SYSTEM OF THE CAT. EFFECT OF STREPTOKINASE, TRYPSIN AND GLYCEROL.
    FLEMING LB; CLIFFTON EE
    J Surg Res; 1965 Apr; 5():153-65. PubMed ID: 14279210
    [No Abstract]   [Full Text] [Related]  

  • 33. THE FORMATION OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-BETA-LIPOPROTEIN COMPLEXES.
    ANDERSON AJ
    Biochem J; 1963 Sep; 88(3):460-9. PubMed ID: 14071519
    [No Abstract]   [Full Text] [Related]  

  • 34. [1st experiences with highly purified streptokinase in thrombolysis in surgery].
    MUELLER K
    Bruns Beitr Klin Chir; 1961 May; 202():340-9. PubMed ID: 13773527
    [No Abstract]   [Full Text] [Related]  

  • 35. [Research on the antifibrinolytic effect of 6-aminocaproic acid. III. Effect of 6-aminocaproic acid as an antidote to thrombolytic agents (plasmin, streptokinase)].
    GIBELLI A
    Gazz Int Med Chir; 1962 Nov; 66():2444-50. PubMed ID: 13947688
    [No Abstract]   [Full Text] [Related]  

  • 36. THE FIBRINOLYTIC SYSTEM IN BLOOD AFTER RETENTION OF A DEAD FETUS AND DURING NORMAL LABOR.
    BRAKMAN P; KING AE
    Am J Obstet Gynecol; 1965 May; 92():221-6. PubMed ID: 14281832
    [No Abstract]   [Full Text] [Related]  

  • 37. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 38. FIBRINOGEN BREAKDOWN PRODUCTS.
    LEWIS JH; WILSON JH
    Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
    [No Abstract]   [Full Text] [Related]  

  • 39. THE EFFECT OF ATROMID-S ON THE FIBRINOLYTIC ENZYME SYSTEM.
    SWEET B; RIFKIND BM; MCNICOL GP
    J Atheroscler Res; 1965; 5(3):347-50. PubMed ID: 14290298
    [No Abstract]   [Full Text] [Related]  

  • 40. INACTIVATION OF STREPTOKINASE BY BOVINE PLASMIN.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():529-32. PubMed ID: 14086328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.